cost action "novel tools for test evaluation and disease prevalence estimation" - dr kostoulas
Published 2 years ago • 279 plays • Length 0:56Download video MP4
Download video MP3
Similar videos
-
0:59
ask dr. michler: percutaneous valve replacement, lvad and the artificial heart
-
12:43
clia from diasorin, italy.
-
3:31
cpap machines recalled by philips over possible release of toxins: what you need to know
-
1:29
philips ingenia elition 3 0t
-
2:19
novel potent and selective flt3 inhibitors
-
8:26
3.2. manual of pci - pharmacology: vasodilators
-
3:33
🦠 inline anti-bacterial cpap filters - philips update
-
58:16
impact of the philips pap recall on patient care and sleep center operations
-
1:08
dr. dreicer on response to immunotherapy in urothelial cancer
-
3:07
3.1. manual of pci - pharmacology: sedation and analgesia
-
1:04
why does cvi have pressure limiting and how does it occur?
-
1:32
anesthesia: a comprehensive review, 5e
-
1:10
updated efficacy results for avelumab in metastatic urothelial carcinoma
-
1:59
how can we best sequence novel treatments in urothelial cancer?
-
3:12
philips elca coronary laser atherectomy catheter mechanisms of action
-
4:57
a 2013 iso 10993 update on biocompatibility
-
0:49
resusci anne simulator - how to replace io insert
-
4:37
metabolic adaptations to targeted therapy in flt3 mutated acute myeloid leukaemia
-
14:32
dr. d. vilades-medel at escr 2016 - ''coronary subtraction''
-
9:22
how to treat balloon uncrossable and undilatable lesions - emmanouil s. brilakis, md, phd
-
3:43
reliability and accuracy of a novel classification system using peroral cholangioscopy...
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy